Pergoveris Contraindications




Zuellig Pharma
Full Prescribing Info
Pergoveris is contraindicated in patients with: hypersensitivity to the active substances follitropin alfa and lutropin alfa or to any of the excipients; case of tumours of the hypothalamus and pituitary gland; ovarian enlargement or cyst not due to polycystic ovarian disease; gynaecological haemorrhages of unknown aetiology; ovarian, uterine or mammary carcinoma.
Pergoveris must not be used when an effective response cannot be obtained, such as: primary ovarian failure, malformations of sexual organs incompatible with pregnancy, fibroid tumours of the uterus incompatible with pregnancy.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in